Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Csizmadia

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Journal of Pharmaceutical Sciences|May 20, 1998
Model-independent estimation of lag times with first-order absorption and dispositionF Csizmadia, L Endrenyi
Journal of Pharmaceutical Sciences|July 1, 1997
Prediction of distribution coefficient from structure. 1. Estimation methodF Csizmadia, A Tsantili-Kakoulidou, I Panderi, et al.
Pharmaceutical Research|August 26, 1998
Metrics comparing simulated early concentration profiles for the determination of bioequivalenceL Endrenyi, F Csizmadia, L Tothfalusi, et al.
Journal of Pharmaceutical Sciences|October 31, 1997
Prediction of distribution coefficient from structure. 2. Validation of Prolog D, an expert systemA Tsantili-Kakoulidou, I Panderi, F Csizmadia, et al.
European Journal of Drug Metabolism and Pharmacokinetics|March 15, 2000
Prediction of distribution coefficients from structure. Comparison of calculated and experimental data for various drugsA Tsantili-Kakoulidou, I Panderi, S Piperaki, et al.
Pharmaceutical Research|May 1, 1998
The duration of measuring partial AUCs for the assessment of bioequivalenceL Endrenyi, F Csizmadia, L Tothfalusi, et al.
Orvosi Hetilap|April 7, 1985
[Questions concerning the use of antibiotics]J Jákics, V Breitner, E Hernádi, et al.
Archiv Der Pharmazie|November 1, 1996
Synthesis and antifungal activities of myristic acid analogsK Parang, E E Knaus, L I Wiebe, et al.
Antiviral Research|May 1, 1997
In vitro antiviral activities of myristic acid analogs against human immunodeficiency and hepatitis B virusesK Parang, L I Wiebe, E E Knaus, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Journal of Pharmaceutical Sciences|May 20, 1998
Model-independent estimation of lag times with first-order absorption and dispositionF Csizmadia, L Endrenyi
Journal of Pharmaceutical Sciences|July 1, 1997
Prediction of distribution coefficient from structure. 1. Estimation methodF Csizmadia, A Tsantili-Kakoulidou, I Panderi, et al.
Pharmaceutical Research|August 26, 1998
Metrics comparing simulated early concentration profiles for the determination of bioequivalenceL Endrenyi, F Csizmadia, L Tothfalusi, et al.
Journal of Pharmaceutical Sciences|October 31, 1997
Prediction of distribution coefficient from structure. 2. Validation of Prolog D, an expert systemA Tsantili-Kakoulidou, I Panderi, F Csizmadia, et al.
European Journal of Drug Metabolism and Pharmacokinetics|March 15, 2000
Prediction of distribution coefficients from structure. Comparison of calculated and experimental data for various drugsA Tsantili-Kakoulidou, I Panderi, S Piperaki, et al.
Pharmaceutical Research|May 1, 1998
The duration of measuring partial AUCs for the assessment of bioequivalenceL Endrenyi, F Csizmadia, L Tothfalusi, et al.
Orvosi Hetilap|April 7, 1985
[Questions concerning the use of antibiotics]J Jákics, V Breitner, E Hernádi, et al.
Archiv Der Pharmazie|November 1, 1996
Synthesis and antifungal activities of myristic acid analogsK Parang, E E Knaus, L I Wiebe, et al.
Antiviral Research|May 1, 1997
In vitro antiviral activities of myristic acid analogs against human immunodeficiency and hepatitis B virusesK Parang, L I Wiebe, E E Knaus, et al.
Pageof 1